Navigation Links
Kosan Biosciences to Present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference
Date:2/29/2008

HAYWARD, Calif., Feb. 29 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) announced today that Gary S. Titus, Kosan's Senior Vice President and Chief Financial Officer, will present at the Susquehanna Second Annual SIGnificant Options in Healthcare Conference in New York at the W Hotel on Tuesday, March 4, 2008 at 10:30 a.m. EST. A live webcast of the presentation can be accessed through http://www.wsw.com/webcast/sig7/kosn/.

Interested parties may also access a live webcast of the presentation by visiting the "Events Calendar" page under the "Investors/Press" tab on Kosan's website at http://www.kosan.com. A recorded replay of the presentations will be available for two weeks.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Tanespimycin (KOS-953) is being tested in combination with bortezomib (Velcade(R)) in patients with multiple myeloma in a clinical program called TIME. Tanespimycin is also being studied in HER2-positive metastatic breast cancer in combination with trastuzumab (Herceptin(R)). Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's motilin agonist compound, KOS-2187, licensed to Pfizer, is in a Phase 1 trial in gastroesophageal reflux disease
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Kosan Biosciences to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference
3. Kosan Biosciences to Present at the Biotechnology Industry Organization Investor Forum
4. Kosan Biosciences to Host Research & Development Day on October 31, 2007
5. Kosan to Reacquire Epothilone Program From Roche
6. Kosan Announces Third Quarter 2007 Financial Results
7. Kosans Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer
8. Kosan Announces February 28, 2008 Conference Call and Webcast
9. Kosan Announces Fourth Quarter and Full Year 2007 Financial Results and 2008 Outlook
10. Kosan Announces Senior Management Changes and Clinical Portfolio Priorities
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., RANCHO CORDOVA, Calif., Nov. 5 /PRNewswire-..., a leading supplier of innovative products for pr...ted results for the first quarter of fiscal 2010. ...e Company reported revenues of $5.2 million, a 15 ...the first quarter a year ago. The Company said the...
(Date:11/5/2009)..., OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/ ...oday announced financial results for the quarter e...esults are presented in the tables that follow. ,...d a net loss of $366,000 or $0.01 per share for th...of $499,000 or $0.01 per share for the third quart...
(Date:11/5/2009)..., SUNNYVALE, Calif., Nov. 5 /PRNewswire-First...that its executives will be speaking at the follow... participate via webcast. , , Cred... Thursday, 12 November, 2009 at 10 a.m....nvestor Program, London, England, ...
(Date:11/5/2009)..., SAN DIEGO, CA, November 5, 2009 /PRNewswire...ompany focused on using proprietary taste receptor...dients for the food, beverage, and ingredient supp...nd reported financial results for the third quarte...llion for the third quarter of 2009, compared to $...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...arch 25 Aethlon Medical, Inc. (OTC Bulletin Board...s the advancement of the Aethlon Hemopurifier(R) a... cure rates. The Hemopurifier(R) is a first-in-cla... in combating infectious disease through real-time...immunosuppressive proteins. In HCV care, the devi...
...ch 25 Cell Therapeutics, Inc. (CTI) (NASDAQ and M...cial Meeting of Shareholders held on Tuesday, Marc...oved the proposal to increase the number of shares... number of shares of authorized common stock), the...le for issuance under its 2007 Equity Incentive Pl...
... from the Department of Energy,s Pacific Northwest...ar,s American Chemical Society 2009 Spring Meeting...occur on Tuesday afternoon. , , Scientists are ho...k down contaminants for environmental cleanup or s...lash of UV light, titanium dioxide can do just tha...
Other Biology Technology:Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 2Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 3Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 4Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates 5Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders 2
(Date:11/9/2009)...avid Queller and Joan Strassmann argue in a new pa... components, from the genetic level on up, give a ...ng is an animal, a plant, a bacteria or a colony.... an organism, such as individuality or even member...achieve organismality. What is necessary, they arg...
(Date:11/9/2009).../ -- Genencor, a division of Danisco, has won the ...can Institute of Chemical Engineers (AIChE) for it...ic ethanol. Yesterday, Robert Davis, Chair of the ...don Steele, who is Marketing Director, Biomass Enz...ron Kelley, who is Senior Engineer, Biomass Applic...
(Date:11/9/2009)...ionist whose research was instrumental in adding f... and Children (WIC) food subsidy will receive the ... achievement in the field of maternal-fetal nutrit...r in the Department of Community Health Sciences a... of Public Health, will receive the award today a...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 1PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 2PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 3PLC Announces That Initial Abstract for Presentation of CCM Study of RenalGuard 28R 29 at ESC 2009 Has Been Published 3B Strong Preliminary Results Se 55252 4LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 55250 1LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 55250 2LATINA Style Magazine Selects Aflac for Annual List of Top 50 Companies 55250 3Hair Loss Being Conquered 55248 1Hair Loss Being Conquered 55248 2
... several years ago, University of Chicago paleonto... Why bother classifying organisms according to the...olutionary dynamics, when molecular techniques had...han a few heads in the audience nodding their agre...in Geophysical Sciences, saw more work to be done....
...nithSolar, an Israeli start-up company, launched i...ased on concentrated photovoltaic (CPV) systems de...rsity of the Negev (BGU). , ZenithSolar Video ...lar Energy and Environmental Physics at BGU,s Jaco...es the new system will harvest more than 70 percen...
...ed UC San Diego Chancellor Marye Anne Fox, local s...upport for a regional partnership designed to deve... Speaking at a news conference on the UC San Dieg...ego region, now home to more than 500 biotechnolog...able energy development, as scientists from UC San...
Other Biology News:Analysis finds strong match between molecular, fossil data in evolutionary studies 2Ben-Gurion University research and technology used in new solar energy farm 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 4Regional partnership to develop algal biofuels gets backing of San Diego leaders 5Regional partnership to develop algal biofuels gets backing of San Diego leaders 6
Chicken Anti-E2F2 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Rabbit Anti-Rat ACTH Antibody, Unconjugated from CHEMICON
Goat Anti-BACE Polyclonal Antibody, Unconjugated from Abcam
Biology Products: